HOLBROOK, N.Y., Nov. 13, 2013 /PRNewswire/ -- Northstar
(OTCPink: MDIN) today announced that it has completed the
design and manufactured the first prototypes of its lactose
intolerance treatment bringing it one step closer to market. Based
on the recently licensed patent, the treatment is like nothing else
available, and will make Northstar stand out far among any
competitors.
The final design of the product comes in the form of a three-day
treatment. Consisting of a pill on days one and two, and
consumption of a small a small 1oz container of yogurt on day
three, which starts a unique process in the digestive system.
Laboratory animals consuming the treatment were rid of all lactose
intolerance symptoms for as long as 90 days.
Northstar's CEO, Nick Chieco
explained, "Every other solution to this problem involves taking
pills before any meal containing lactose. Forgetting to do so, or
consuming lactose-containing foods without realizing it can be
extremely uncomfortable and even painful for those afflicted. This
product does more than offer a treatment for a few uncomfortable
symptoms, it offers total freedom to people ordinarily shackled to
restrictive diets and carrying around pills everywhere they go." He
goes on to say, "The company has been overwhelmed with interest
from potential partners, investors, the retail community and
others, and despite the success of Snorenz and the other product
line, It's my feeling that this, yet unnamed product is going to
define Northstar's future even before it is released to the
public."
This announcement comes at the end of an extremely busy few
months. Currently Northstar has been shipping additional product to
retail chains and distributors gearing up for release to shelves on
the national level, and although that benchmark in the company's
history was originally expected to happen almost a year ago,
Northstar would like to assure shareholders that the result will be
worth the wait. The company originally planned for release as a
promotional display product, but because of solid sales and
customer demand, will end up going straight to permanent homes in
the shelf plans of some major retailers. Additionally, the
company has been in the middle of auditing it's books for the past
two years to become fully reporting, a daunting task that the
company hopes to have completed by the first of the year, so it can
be released along with the 2013 annual disclosure.
Month after month Northstar's sales continue to grow, and the
company continues to gain position for what it hopes is a sprint to
the big leagues of alternative healthcare products.
About Northstar
Northstar Global Business Services is dedicated to producing the
best alternative healthcare products to the world. The company's
varied product line includes Snorenz®, Snorenz Night Time ™, Good
Night's Sleep®, Stem-Intense, and Health Enrich for Pets™. Most of
the company's products use a unique or patented spray delivery
system, and all have received rave consumer reviews all over the
world, selling millions of units from 1996 to the present. For more
information about Northstar, Contact Investor Relations at
1-877-571-4387 or Email: investors@northstarbb.com
DISCLAIMER
This Press Release may contain certain forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995. The Company has tried, whenever possible, to identify
these forward-looking statements using words such as "anticipates,"
"believes," "estimates," "expects," "plans," "intends," "potential"
and similar expressions. These statements reflect the Company's
current beliefs and are based upon information currently available
to it. Accordingly, such forward-looking statements involve known
and unknown risks, uncertainties and other factors which could
cause the Company's actual results, performance or achievements to
differ materially from those expressed in or implied by such
statements. The Company undertakes no obligation to update or
advise in the event of any change, addition or alteration to the
information catered in this Press Release including such
forward-looking statements.
SOURCE Northstar Global Business Services